NKTR-422 demonstrated inflammation resolution and tissue repair in multiple preclinical models of chronic inflammatory conditions - SAN FRANCISCO, Nov. 18, 2024 ...
AECOM (NYSE:ACM), the trusted global infrastructure leader, today reported fourth quarter and full year fiscal 2024 results. Fourth Quarter Fiscal 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback